These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?]. Mearin F, Perelló A, Balboa A. Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413 [Abstract] [Full Text] [Related]
10. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Whelan K, Quigley EM. Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925 [Abstract] [Full Text] [Related]
11. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome? Burgmann T, Clara I, Graff L, Walker J, Lix L, Rawsthorne P, McPhail C, Rogala L, Miller N, Bernstein CN. Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762 [Abstract] [Full Text] [Related]
12. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases]. Mekkel G, Barta Z, Ress Z, Gyimesi E, Sipka S, Zeher M. Orv Hetil; 2005 Apr 24; 146(17):797-802. PubMed ID: 17918636 [Abstract] [Full Text] [Related]
13. IBS and IBD - separate entities or on a spectrum? Spiller R, Major G. Nat Rev Gastroenterol Hepatol; 2016 Sep 26; 13(10):613-21. PubMed ID: 27667579 [Abstract] [Full Text] [Related]
14. Perceptions of gastroenterologists and patients regarding irritable bowel syndrome and inflammatory bowel disease. Levy S, Segev M, Reicher-Atir R, Steinmetz A, Horev N, Niv Y, Dickman R. Eur J Gastroenterol Hepatol; 2014 Jan 26; 26(1):40-6. PubMed ID: 24025978 [Abstract] [Full Text] [Related]
15. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Berrill JW, Green JT, Hood K, Campbell AK. Aliment Pharmacol Ther; 2013 Jul 26; 38(1):44-51. PubMed ID: 23668698 [Abstract] [Full Text] [Related]
16. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Vicario M, Guilarte M, Alonso C, Yang P, Martínez C, Ramos L, Lobo B, González A, Guilà M, Pigrau M, Saperas E, Azpiroz F, Santos J. Brain Behav Immun; 2010 Oct 26; 24(7):1166-75. PubMed ID: 20600818 [Abstract] [Full Text] [Related]
18. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. J Clin Gastroenterol; 2012 Oct 26; 46 Suppl():S52-5. PubMed ID: 22955358 [Abstract] [Full Text] [Related]